Researchers test mRNA technology for universal flu vaccine
An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.
The two-dose vaccine employs the same messenger RNA (mRNA)technology used in the COVID-19 shots developed by Pfizer PFE.N with BioNTech 22UAy.DE, and by Moderna MRNA.O. It delivers tiny lipid particles containing mRNA instructions for cells to create replicas of so-called hemagglutinin proteins that appear on influenza virus surfaces.
A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.
"The idea here is to have a vaccine that will give people a baseline level of immune memory to diverse flu strains, so that there will be far less disease and death when the next flu pandemic occurs," study leader Scott Hensley of the Perelman School of Medicine at the University of Pennsylvania said in a statement.
Unlike standard flu vaccines that deliver one or two versions of hemagglutinin, the experimental vaccine includes 20 different types in the hope of getting the immune system to recognize any flu virus it might encounter in the future.
In lab experiments, vaccinated animals' immune systems recognized the hemagglutinin proteins and defended against 18 different strains of influenza A and two strains of influenza B. Antibody levels induced by the vaccine remained unchanged for at least four months, according to a report published in the journal Science.
The vaccine reduced signs of illness and protected from death even when the ferrets were exposed to a different type of flu not in the vaccine, the researchers said.
Moderna and Pfizer both have mRNA flu vaccines in late-stage human trials, and GSK GSK.L and partner CureVac 5CV.DE are testing an mRNA flu vaccine in an early-stage safety trial in humans. These vaccines are designed to defend against only four recently-circulating influenza strains but could theoretically be changed up each year.
The universal flu vaccine, if successful in human trials, would not necessarily prevent infection. The goal is to provide durable protection against severe disease and death, Hensley said.
Questions remain regarding how to judge efficacy and potential regulatory requirements for a vaccine against possible future viruses that are not currently circulating, Alyson Kelvin and Darryl Falzarano of the University of Saskatchewan, Canada, wrote in a commentary published with the study.
While the promising results with the new vaccine "suggest a protective capacity against all subtypes of influenza viruses, we cannot be sure until clinical trials in volunteers are done," Adolfo García-Sastrem, director of the Institute for Global Health and Emerging Pathogens at Mount Sinai Hospital in New York, said in a statement.
Reporting by Nancy Lapid; Editing by Christine Soares and Bill Berkrot
COVID-19 COVERAGE
CTVNews.ca Top Stories
BREAKING | Canada deploys military assessment team to Turkiye after earthquake
A senior government official says a Canadian military assessment team is on its way to Turkiye in the wake of a devastating earthquake that's killed thousands.

'It was a nightmare': 2 children dead, driver charged after city bus crashes into Laval daycare
A man has been arrested and two children are dead after a driver crashed a city bus into a daycare in Laval, Que. Wednesday morning. The deadly crash sent multiple children to area hospitals and parents scrambling to find their kids shortly after they dropped them off for the day at the Garderie éducative Sainte-Rose, north of Montreal.
'There are no words': Laval daycare bus crash prompts outpouring of condolences on Parliament Hill
Condolences are pouring in on Parliament Hill after a Laval, Que., city bus crashed into a daycare on Wednesday morning, with federal politicians of all stripes expressing their sympathies with the families affected and gratitude to the first responders.
opinion | Before you do your taxes, take note of these tax credits and deductions you may not have known about
Many Canadians are experiencing strains caused by the increased cost of living and inflation. In his exclusive column for CTVNews.ca, contributor Christopher Liew shares some of the top credits and deductions that you may be able to claim on your income tax return to help you save money.
5 key takeaways from the BoC's first summary of interest rate deliberations
In a first for the Bank of Canada, it has released a summary of deliberations by its governing council regarding its policy decision to raise its key interest rate target by a quarter of a percentage point to 4.5 per cent in January. Here are five key takeaways from those discussions.
Netflix Canada begins password sharing crackdown
Netflix Canada is rolling out its long-anticipated plans to crack down on password sharing, saying it will begin notifying Canadian users today by email about limitations.
Health-care workers have new hand-washing guidelines. Here's how you can apply them
The way respiratory viruses have circulated this fall and winter, most Canadians could probably benefit from a hand-hygiene refresher. Here are the latest hand-washing best practices to apply in your daily life.
Labour shortages could push up wages, 'reignite inflation' in long run, report warns
Protracted labour shortages in Canada could fuel more rapid wage growth and inflation over time, potentially prompting the need for higher interest rates long-term, a new RBC Economics report released Wednesday said.
Bank of Canada releases details on interest rate decision for the first time
The Bank of Canada released a summary of its Governing Council meetings on Wednesday, providing the public and financial institutions with more insight into the central bank’s decision to raise its key interest rate on Jan. 25.